Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy - Sagen, J V; Raeder, H; Hathout, E; Shehadeh, N; Gudmundsson, K; Baevre, H; Abuelo, D; Phornphutkul, C; Molnes, J; Bell, G I; Gloyn, A L; Hattersley, A T; Molven, A; Sovik, O; Njolstad, PR (Diabetes, 2004)
EK III